ANDA Sponsors Knock Out Key US Entresto Patent, Mylan Falls To Infringement

Mixed Rulings Delivered Across Two Courts, Albeit With Major Win For Trio

Entresto, one of the major small molecule opportunities for ANDA sponsors in the US, has seen a key patent knocked out following a challenge by generics manufacturers.

Novartis
• Source: Shutterstock

More from Legal & IP

More from Generics Bulletin